Tonix Pharmaceuticals Holding Corp.
For the period ended Jun 30, 2025. Filed Aug 11, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 11, 2025
TNXP$4.10-8.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2C. Purchases of Equity Securities
The following table shows the activity related to our share repurchase program for the three months ended June 30, 2025:
| Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1) | Maximum Number (or Approximate Dollar Value) of Shares that May Yet be Purchased Under the Plans or Programs | |
|---|---|---|---|---|
| September 2024 Program | ||||
| April 1 through April 30, 2025 | — | $— | — | $— |
| May 1 through May 31, 2025 | 150,000 | 19.31 | 150,000 | 4,051,125 |
| June 1 through June 30, 2025 | — | — | — | $— |
| Second Quarter Total | 150,000 | $19.31 | 150,000 | $4,051,125 |
| (1) | On September 6, 2024, the Board of Directors approved a share repurchase program pursuant to which the Company may purchase up to $10.0 million in value of its outstanding common stock from time to time on the open market and in privately negotiated transactions subject to market conditions, share price and other factors. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.